Drug profile · INN
lebrikizumab
EBGLYSS
- Patents linked
- 0
- News articles
- 0
Quick answer
lebrikizumab (EBGLYSS) is an FDA-listed pharmaceutical active ingredient. Associated with S.A..
Key facts
Frequently asked questions
What is lebrikizumab?
lebrikizumab (EBGLYSS) is an FDA-listed pharmaceutical active ingredient. Associated with S.A..
What is the brand name for lebrikizumab?
EBGLYSS is a marketed brand name for lebrikizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.